Terragen Holdings Limited (ASX:TGH)
Australia
· Delayed Price · Currency is AUD 0.0300
+0.0010 (3.45%)
Apr 24, 2025, 12:17 PM AEST
Terragen Holdings Company Description
Terragen Holdings Limited engages in the research, development, production, and sale of biological products for the agriculture sector in Australia and New Zealand.
It offers Mylo, a microbial feed supplement for animals; and Great Land Plus, a biostimulant plant product.
Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.
Terragen Holdings Limited
| Country | Australia |
| Founded | 1996 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| CEO | Richard Norton |
Contact Details
Address: 39 Access Crescent Coolum Beach, 4573 Australia | |
| Phone | 1300 837 724 |
| Website | terragen.com.au |
Stock Details
| Ticker Symbol | TGH |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000062333 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Richard Lawrence Norton GAICD, M.B.A. | Chief Executive Officer, MD and Non-Executive Director |
| Matthew Whyte | Chief Financial Officer and Company Secretary |
| Dr. Jocelyn West | Chief Operating Officer |
| Adam Davies | Head of Sales and Marketing |
| Dr. Paul Schober | Advisor |
| Dr. Karen Jury | Head of Research and Development |
| Dr. Paul Scott | Head of Soil Health Product Development |
| Andrew Wollen | Head of New Product Applications Development |